#Sweden #India #Stockholm #Medicover #Hospital

Medicover's Future in India: A Potential Separate Listing

In a significant move to bolster its growth in the rapidly expanding Indian healthcare market, Medicover AB (Publ) has announced its intention to explore the possibility of a separate stock listing for its Indian hospital subsidiary. The decision was made by the company's board of directors, highlighting their commitment to fostering growth and expansion within India over the next 12 to 24 months.

Understanding Medicover and Its Operations in India

Founded in 1995, Medicover is a globally recognized healthcare and diagnostic services provider. The organization operates numerous facilities including hospitals, outpatient clinics, and laboratories, with its major markets being Poland, Germany, Romania, and India.
In India, Medicover Hospitals operates 23 hospitals and 2 cancer centers across four key states: Andhra Pradesh, Karnataka, Maharashtra, and Telangana. As of the end of the third quarter of 2024, Medicover recorded impressive revenue figures from its operations in India, totaling €196.9 million over the last year. This success underscores the potential that the company sees in the Indian market.

Plans for Future Expansion

Medicover is poised for further expansion within India. The company has committed to opening two new hospitals in 2025 and early 2026. This move is expected to enhance their service offerings and footprint within the burgeoning healthcare market. The evaluated separate listing is being viewed as a strategic maneuver to fortify their operational base and capitalize on the anticipated growth in the sector.

Listing Evaluation Timeline

The evaluation for the separate listing is projected to take approximately 12 to 24 months. Throughout this period, Medicover is expected to provide updates on its progress and decision-making processes regarding the potential listing. This step could position Medicover well among other players in the Indian healthcare market, as public funding could facilitate further growth and investment.

Impact on the Market

Should Medicover proceed with the listing, it may attract attention from both local and international investors, providing a unique investment opportunity in a sector that is rapidly evolving and becoming increasingly vital. The healthcare landscape in India is marked by consistent growth, driven by both government initiatives and private sector investments. As per recent reports, the demand for medical facilities is rising, primarily due to increasing health awareness among the populace and the need for advanced medical care.

Conclusion

Medicover AB's initiative to evaluate a potential separate listing in India is a testament to its robust growth strategy in a competitive healthcare environment. As the company navigates through this evaluation process, stakeholders and potential investors will keenly watch the developments, anticipating updates that could reshape Medicover's trajectory in one of the world's most dynamic healthcare markets.

For ongoing updates regarding this evaluation process, stakeholders are encouraged to remain informed through corporate communications and official announcements.

For more detailed inquiries, contact Hanna Bjellquist, Head of Investor Relations at Medicover, at +46 703 033 272 or via email.